share_log

Mineralys Therapeutics | 4: Statement of changes in beneficial ownership of securities-Chief Executive Officer Congleton Jon

SEC announcement ·  Nov 27, 2023 16:01
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more